Journals
RSS Feed Readers

Filter by Tag:   Date:
Journals
07
Jul

Pentamethylquercetin as a Potential Antidiabetic Agent

Posted by: Admin

Y. Wang and colleague report potential antidiabetic activity of Pentamethylquercetin Recent research report, “Anti-diabetic effects of pentamethylquercetin...Read More

22
May

Sunitinib, A New Drug For Advanced Pancreatic Neuroendocrine Tumors

Posted by: Admin

US FDA Approves New drug For Advanced Pancreatic Neuroendocrine Tumors ...Read More

06
May

Afinitor as the First New Treatment for Pancreatic Cancer

Posted by: Admin

Afinitor as first new treatment for Pancreatic Cancer, Novartis gets FDA approval ...Read More

05
May

Abbott’s Novel AndroGel 1.62% gets US FDA approval for Hypogonadism

Posted by: Admin

Abbott Receives U.S. FDA Approval for AndroGel® 1.62% to Treat Men with Low Testosterone ...Read More

04
May

Linagliptin Monotherapy gets US FDA nod for Type 2 diabetes

Posted by: Admin

Linagliptin, the dipeptidyl peptidase inhibitor gets nod from US Food and Drug Administration ...Read More

18
Apr

BYDUREON To Become First Once-Weekly Treatment for Adults with Type 2 Diabetes

Posted by: Admin

BYDUREON To Become First Once-Weekly Treatment for Adults with Type 2 Diabetes BYDUREN is...Read More

18
Apr

Investigational Drug Metreleptin, A Human Hormone Leptin Analog: Amylin Inc. Presents Data

Posted by: Admin

Metreleptin Treatment Led to Long-Term Improvements in Diabetes and Lipid Control in Patients with Lipodystrophy: Amylin Pharma Presents Data ...Read More

14
Apr

BioSante Pharmaceutical’s Teva Bio-T-Gel accepted as New Drug Application by US FDA

Posted by: Admin

Bio-T-Gel for the Treatment of Male Hypogonadism is Accepted as New Drug Application by US FDA ...Read More

14
Apr

Sanofi-aventis Announces Positive Top-line Lixisenatide Phase III Results

Posted by: Admin

Lixisenatide Reduces HbA1c without Increasing Hypoglycemia in Sulfonylureas Resistant Patients ...Read More

11
Apr

Zydus’s IND Application of ZYGK1 for Treating Diabetes Gets USFDA Nod

Posted by: Admin

Ahmedabad, INDIA Zydus Cadila, a global healthcare provider and one of India’s leading healthcare companies announced that it has received an approval...Read More

Journals are primarily meant for Medical practitioners and healthcare service providers to find out what’s new and happening in the medical world. Latest scientific breakthroughs, research, events and conferences will all be there for you. This section of HealthLine 24x7 will ensure that you are constantly updated on the latest discovery, innovation and experiment. You can browse through the journal content available on HealthLine 24x7 either date wise or category wise. The current categories available are Cardiology, Neurology and Oncology. The few journals available on Healthline24x7 currently are, “Alzheimer and Heart Disease Share a Common Gene according To the Latest Research,” “A Ray of Hope for Patients with Severe Aortic Stenosis,” “Vioxx and Heart Attack-The Mystery Solved,” “Repairing Damaged Hearts, Naturally,” “To Get A Mammogram Or Not.”